메뉴 건너뛰기





Volumn 3, Issue 4, 2004, Pages 337-354

Heart, rheumatism and autoimmunity: Milan, Italy. February 5-7, 2004

Author keywords

2 glicoprotein I; 2GPI; aCL; anticardiolipin antibodies; antiphospholipid antibodies; antiphospholipid antibodies syndrome; aPL; APS; cardiac heart disease; CHB; CHD; congenital heart block; COX; COX 2 inhibitors; Coxibs; CRP; cyclooxygenase

Indexed keywords

ACETYLSALICYLIC ACID; ADALIMUMAB; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; ARGATROBAN; AUTOANTIBODY; C REACTIVE PROTEIN; CD28 ANTIGEN; CD4 ANTIGEN; CELECOXIB; CYCLOOXYGENASE 2 INHIBITOR; CYTOKINE; ESTROGEN; ETANERCEPT; FARNESOL; GERANYLGERANIOL; HEPARIN; INFLIXIMAB; MARKER; MELAGATRAN; METHOTREXATE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PENTASACCHARIDE; ROFECOXIB; STATIN; THROMBIN INHIBITOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; UNINDEXED DRUG;

EID: 3042772073     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2004.03.005     Document Type: Conference Paper
Times cited : (4)

References (0)
  • Reference 정보가 존재하지 않습니다.

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.